Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency. - Wikidata - wikimedia - TriplyDB

Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency.

Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency.

http://www.wikidata.org/entity/Q43130211

about

Herpes simplex virus and varicella zoster virus, the house guests who never leave Towards a rational design of an asymptomatic clinical herpes vaccine: the old, the new, and the unknown HSV-2: in pursuit of a vaccine Targeted DNA mutagenesis for the cure of chronic viral infections Immune modulation during latent herpesvirus infection Tissue-resident memory T cells Bovine Herpes Virus 1 (BHV-1) and Herpes Simplex Virus Type 1 (HSV-1) Promote Survival of Latently Infected Sensory Neurons, in Part by Inhibiting Apoptosis Herpes simplex virus type 1 latency and reactivation: an update Immune regulation of human herpesviruses and its implications for human transplantation A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation T cell memory in the context of persistent herpes viral infections The molecular basis of herpes simplex virus latency A cultured affair: HSV latency and reactivation in neurons Immunological aspects of acute and recurrent herpes simplex keratitis The challenges and opportunities for the development of a T-cell epitope-based herpes simplex vaccine Therapeutic antiviral T cells noncytopathically clear persistently infected microglia after conversion into antigen-presenting cells Illuminating viral infections in the nervous system Local CD4 and CD8 T-cell reactivity to HSV-1 antigens documents broad viral protein expression and immune competence in latently infected human trigeminal ganglia Mathematical Modeling Predicts that Increased HSV-2 Shedding in HIV-1 Infected Persons Is Due to Poor Immunologic Control in Ganglia and Genital Mucosa Neurons are MHC class I-dependent targets for CD8 T cells upon neurotropic viral infection Keeping it in check: chronic viral infection and antiviral immunity in the brain Leukocyte protease binding to nucleic acids promotes nuclear localization and cleavage of nucleic acid binding proteins A natural genetic variant of granzyme B confers lethality to a common viral infection Diversity in CD8(+) T cell function and epitope breadth among persons with genital herpes.De novo synthesis of VP16 coordinates the exit from HSV latency in vivo.Ocular and neural distribution of feline herpesvirus-1 during active and latent experimental infection in cats.Towards an understanding of the herpes simplex virus type 1 latency-reactivation cycle Interferon alpha induces establishment of alphaherpesvirus latency in sensory neurons in vitro.Herpes simplex type I (HSV-1) infection of the nervous system: is an immune response a good thing?Memory CD8+ T cell differentiation Public TCR use by herpes simplex virus-2-specific human CD8 CTLs.A herpes simplex virus 2 (HSV-2) glycoprotein D-expressing nonreplicating dominant-negative HSV-2 virus vaccine is superior to a gD2 subunit vaccine against HSV-2 genital infection in guinea pigs T cells facilitate recovery from Venezuelan equine encephalitis virus-induced encephalomyelitis in the absence of antibody.Granzyme B-induced and caspase 3-dependent cleavage of gelsolin by mouse cytotoxic T cells modifies cytoskeleton dynamics.Reversible nerve damage and corneal pathology in murine herpes simplex stromal keratitis.Lytic gene expression is frequent in HSV-1 latent infection and correlates with the engagement of a cell-intrinsic transcriptional response Expression of herpes simplex virus 1-encoded microRNAs in human trigeminal ganglia and their relation to local T-cell infiltrates.Deregulation of mitochondrial membrane potential by mitochondrial insertion of granzyme B and direct Hax-1 cleavage.Characterization of the host immune response in human Ganglia after herpes zoster.Delaying the expression of herpes simplex virus type 1 glycoprotein B (gB) to a true late gene alters neurovirulence and inhibits the gB-CD8+ T-cell response in the trigeminal ganglion

P2860

Q21195896-786ED51F-2245-4864-B2E4-5FFE6EACBD26 Q21296712-E3E7ADE9-627C-4D95-AA0D-040DFC52901C Q22306291-06B3BFF6-9B02-4A03-B30A-92694E04F249 Q24620150-B31A926C-713D-45CF-A14D-1AEBE74C4400 Q24624044-0BE37E2B-4A23-452C-80CB-800B8C8DF5BB Q26829804-EA4B3DF1-BC95-4831-97B5-F6A0513D1EE6 Q26864175-4E4A33F5-EE61-45B4-A487-6140A9552AA3 Q26866072-560B8A63-B1C1-40BD-BF8D-36F5A60B023F Q26992146-92E530AA-D332-42E4-826C-B859F3FC387E Q26996418-3848D285-85E3-4052-B8E1-3618DA8E2590 Q26999125-40117F17-E263-408B-8CE2-08200C3071B5 Q27001272-41B3516F-50ED-4576-90A1-EBCEC137CBCC Q27015883-778F9FEC-58F0-474A-9657-D15F186A8BA2 Q27016103-149E1EF8-AD79-4754-ACB0-3D83BD0A495A Q27021292-31618618-8245-4624-8FC5-BC96DB58D6C5 Q27308832-9D219422-E05B-4C70-BCF7-6BD61B3E5C91 Q27310280-35D0BC46-AD4C-4583-96CF-AA96190A3052 Q27333997-0B448860-C89B-407D-AF6E-1BFEE17C7C68 Q27347896-83CE8761-6380-4159-B08C-25B49E251A16 Q27348449-2FE10D10-3289-451E-B9E0-197ACD1C5C74 Q27787368-A1712D9C-476B-4E3F-905B-FEBF756F9CBC Q28238936-0A994A01-4FB6-47A3-B946-97967A3403BF Q28542688-B83166F6-0630-4E5E-9922-F41DACD4943D Q30496837-0AC7A300-475C-406A-9A58-EC00D4B6B9FC Q33422983-89453D27-95BF-4F1C-8502-793188F053EC Q33592391-0176E639-E453-430E-B4A8-6583268C974D Q33654414-D0EC0950-3373-4773-BF59-5EE54E171D84 Q33711923-DA0AC4E5-49BD-4DE8-8DB1-2D37102DD7A7 Q33716707-3B6F2FF8-2FB9-4FD3-9166-9B785DB37619 Q33720379-13CA4328-712B-4ECD-A670-7A611A1B367F Q33824488-30BC1A9C-6921-47A9-84F1-09DB704654D9 Q33825931-522119A1-BDBE-4501-BA59-7B5D96A5C6F0 Q33826627-E68BEF1D-D4C0-4B6C-9EF8-0B050D507D4D Q33897989-348C5550-8E42-427B-80B6-738EDBCDBF78 Q33900294-55FF59B6-5373-44BC-B951-C578D9CC5FDD Q33946164-53E656D0-A7CC-4DBB-B9DD-D9C4B1E8757F Q33973309-F1724FEF-D1B0-4124-A64D-2A40D922102A Q33991174-DDD99CC0-0016-4029-B5EB-3C84F1427EFE Q34055440-3EF8B719-25A2-4EE8-8CEA-50B65ED98FE7 Q34055494-4AEC7A3D-5190-4CB1-8107-17B7862EF609

P2860

Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency.

http://www.wikidata.org/entity/Q43130211

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Noncytotoxic lytic granule-med ...... ivation from neuronal latency.

@en

Noncytotoxic lytic granule-med ...... ivation from neuronal latency.

@nl

type

label

Noncytotoxic lytic granule-med ...... ivation from neuronal latency.

@en

Noncytotoxic lytic granule-med ...... ivation from neuronal latency.

@nl

prefLabel

Noncytotoxic lytic granule-med ...... ivation from neuronal latency.

@en

Noncytotoxic lytic granule-med ...... ivation from neuronal latency.

@nl

P1433

Q43130211-CB2EF956-4889-42DB-8747-5EB3F727878C

P1476

Q43130211-B0B53BB2-3AC9-4E69-B5DF-13E753BD78D0

P2093

Q43130211-2FCC383A-CCB2-43F9-82AA-BF8390F66DE8

Q43130211-30981019-A07A-4489-9480-A94FB959B2C0

Q43130211-43CD556E-3296-485E-856A-EB029C648535

Q43130211-668B4C0C-8784-4D56-9AF6-91DCDC84D190

Q43130211-A2A9DAD9-AF01-40BF-9C70-F523203BF84D

Q43130211-F72DB90B-E54A-4A65-9EEF-B4CF10C031BF

P2860

Q43130211-08F08B8F-1E81-456B-AFCE-A242ED2E21C5

Q43130211-243B58D0-13C0-41F6-8E14-7F864AC67501

Q43130211-48C0BF82-B501-4BDE-A447-CB0167F4E342

Q43130211-563147D9-3472-43B1-92BB-10ED35A5304D

Q43130211-7092AC3B-040E-4172-ACA0-005A067CDE47

Q43130211-7980E5F4-8B78-4AE5-834A-14E07E6E1AF7

Q43130211-86E5F60F-1535-4680-8D12-945804FDCBE2

Q43130211-87BEBDCA-355E-49A7-AF00-F1854F7C01FB

Q43130211-8B04ADCC-9AB6-4934-9669-4EDCF3D143D5

Q43130211-8CD75F3D-04D4-48CC-8400-4B7C980CCE5F

P304

Q43130211-B2541FBB-A631-4319-A136-CC42902DBB5C

P31

Q43130211-B3109308-9314-41D6-8E79-BF151C47B658

P356

Q43130211-A8F6A58C-A811-4D5C-A861-8C6C5A297ADD

P407

Q43130211-B6CD2957-ABD5-40DC-A8D9-1A1F2344AFA7

P433

Q43130211-C75EE495-826C-49A8-B458-D799BE78AD0C

P478

Q43130211-D090C98A-1322-472F-AE55-B44C114D8699

P577

Q43130211-619158C1-A50D-4130-8D56-9650A9EB8C31

P5875

Q43130211-F7CEBEDB-A8B0-4E2B-85ED-403DCD790DD8

P698

Q43130211-D09CBDC5-38C9-4EE4-9C64-65915E09F4A3

P932

Q43130211-54A305A4-33B3-4602-9230-335C7EFBA0FF

P356

SCIENCE.1164164

P1433

P1476

Noncytotoxic lytic granule-med ...... ivation from neuronal latency.

@en

P2093

Catherine J Baty

http://www.w3.org/2001/XMLSchema#string

Jared E Knickelbein

http://www.w3.org/2001/XMLSchema#string

Kamal M Khanna

http://www.w3.org/2001/XMLSchema#string

Michael B Yee

http://www.w3.org/2001/XMLSchema#string

Paul R Kinchington

http://www.w3.org/2001/XMLSchema#string

Robert L Hendricks

http://www.w3.org/2001/XMLSchema#string

P2860

Granzyme H destroys the function of critical adenoviral proteins required for viral DNA replication and granzyme B inhibition

Selective retention of herpes simplex virus-specific T cells in latently infected human trigeminal ganglia

GraBCas: a bioinformatics tool for score-based prediction of Caspase- and Granzyme B-cleavage sites in protein sequences.

Detection of localized caspase activity in early apoptotic cells by laser scanning cytometry.

Presence of HSV-1 immediate early genes and clonally expanded T-cells with a memory effector phenotype in human trigeminal ganglia.

Granzyme A, a noncytolytic component of CD8(+) cell granules, restricts the spread of herpes simplex virus in the peripheral nervous systems of experimentally infected mice.

Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons.

Herpes simplex virus-specific memory CD8+ T cells are selectively activated and retained in latently infected sensory ganglia

Gamma interferon can block herpes simplex virus type 1 reactivation from latency, even in the presence of late gene expression

The early expression of glycoprotein B from herpes simplex virus can be detected by antigen-specific CD8+ T cells.

P304

268-271

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCIENCE.1164164

http://www.w3.org/2001/XMLSchema#string

P407

P433

5899

http://www.w3.org/2001/XMLSchema#string

P478

322

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23310066

http://www.w3.org/2001/XMLSchema#string

P698

18845757

http://www.w3.org/2001/XMLSchema#string

P932

2680315

http://www.w3.org/2001/XMLSchema#string